8th Circ. Revives DOD Fraud Claims In Bayer FCA Suit

Law360, New York (October 15, 2013, 3:25 PM ET) -- The Eighth Circuit on Tuesday revived a False Claims Act suit alleging Bayer AG misled the U.S. Department of Defense about the risks of its now-defunct cholesterol-lowering drug Baycol, finding the DOD allegations were properly brought under the fraud-in-the-inducement theory.

A divided panel for the appeals court held that former Bayer senior market research analyst Laurie Simpson's accusations that Bayer fraudulently induced the DOD to enter into a roughly $11.9 million contract extension for the purchase of Baycol sufficiently identified the “who, what, where, when and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Laurie Simpson v. Bayer Healthcare, et al


Case Number

12-2979

Court

Appellate - 8th Circuit

Nature of Suit

3365 Personal Injury-Product Liability

Date Filed

August 22, 2012

Law Firms

Companies

Government Agencies